Literature DB >> 9213369

Degradation of human adrenomedullin(1-52) by plasma membrane enzymes and identification of metabolites.

L K Lewis1, M W Smith, S O Brennan, T G Yandle, A M Richards, M G Nicholls.   

Abstract

Very little is known about degradation or metabolism of adrenomedullin. To this end, we incubated adrenomedullin with ovine adrenal, kidney and lung plasma membrane preparations and showed the major degradation products were ADM(2-52) and ADM(8-52). Smaller amounts of ADM(26-52), (27-52), (28-52) and (33-52) were also produced. Degradation was inhibited by EDTA and 1,10 phenanthroline but not by phosphoramidon, leupeptin and pepstatin. The above data are consistent with initial hydrolysis adjacent to hydrophobic residues by a metalloprotease, generating ADM(8-52), (26-52) and (33-52), followed by an aminopeptidase action to produce ADM(2-52), (27-52) and (28-52). Improved understanding of the metabolism of ADM may have therapeutic implications, for example in the treatment of heart failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213369     DOI: 10.1016/s0196-9781(97)00005-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  Novel neurohumoral factors in congestive heart failure: adrenomedullin.

Authors:  J G Lainchbury
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

2.  Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP).

Authors:  I B Wilkinson; C M McEniery; K H Bongaerts; H MacCallum; D J Webb; J R Cockcroft
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 3.  Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation.

Authors:  Katharina E M Hellenthal; Laura Brabenec; Nana-Maria Wagner
Journal:  Cells       Date:  2022-06-15       Impact factor: 7.666

4.  Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator.

Authors:  Alfredo Martínez; Hae-Ryong Oh; Edward J Unsworth; Claudia Bregonzio; Juan M Saavedra; William G Stetler-Stevenson; Frank Cuttitta
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

Review 5.  Antimicrobial peptides: natural effectors of the innate immune system.

Authors:  Katherine Radek; Richard Gallo
Journal:  Semin Immunopathol       Date:  2007-04       Impact factor: 11.759

6.  Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure.

Authors:  Miriam T Rademaker; Christopher J Charles; M Gary Nicholls; A Mark Richards
Journal:  Clin Sci (Lond)       Date:  2012-05       Impact factor: 6.124

Review 7.  Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis.

Authors:  Christopher Geven; Matthijs Kox; Peter Pickkers
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

Review 8.  Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.

Authors:  D van Lier; M Kox; P Pickkers
Journal:  J Intern Med       Date:  2020-12-30       Impact factor: 8.989

9.  Antimicrobial activity does not predict cytokine response to adrenomedullin or its shortened derivatives.

Authors:  Quratul Ann Hussain; Barry E Sheehan; Ian J McKay; Robert P Allaker
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

10.  Epitope specificity of anti-Adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model.

Authors:  Joachim Struck; Frauke Hein; Siegmund Karasch; Andreas Bergmann
Journal:  Intensive Care Med Exp       Date:  2013-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.